| Course | NURS 8710 Doctoral Seminar I |
|---|---|
| Week | Week 5 |
| Paper type | Critical appraisal paper |
| Length | About 1,000 words, 6 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Doctor of Nursing Practice (DNP) |
| Updated | October 2026 |
Free sample paper for NURS 8710 Week 5
What the Design Can Support and What This Study Showed: A Critical Appraisal of a Prospective Cohort Evaluating an ICU Mobility Team
Student Name
College of Nursing, Walden University
NURS 8710: Doctoral Seminar I
Instructor Name
Month Day, Year
What the Design Can Support and What This Study Showed: A Critical Appraisal of a Prospective Cohort Evaluating an ICU Mobility Team
The Claim Under Appraisal
This appraisal examines one study in the review's evidence table: a prospective cohort study of a mobility protocol for patients with acute respiratory failure in a university medical intensive care unit (Morris et al., 2008). The study's own conclusion is the target. Its authors conclude that a mobility team using a protocol initiated earlier physical therapy that was feasible, safe and cost-neutral, and that it was associated with decreased ICU and hospital length of stay in survivors who received physical therapy in the ICU, compared with usual care.
The appraisal keeps two questions apart throughout. The first is what a prospective cohort comparison of this kind can establish in principle. The second is what happened when these investigators carried it out. A strong design can be badly executed, and a limited design can be carried out carefully; mixing the two questions produces verdicts that are either too generous or too harsh. The appraisal draws on the JBI checklist for cohort studies (Moola et al., 2020) and on the standard account of threats to validity in nonrandomized designs (Shadish et al., 2002). It is based on the published report as summarized in its abstract, and claims are limited to what the report states.
Design: What a Prospective Cohort Comparison Can Establish
The study compared 165 patients managed under the mobility protocol with 165 receiving usual care. Because patients were not randomly assigned, the design can establish that outcomes differed between the groups, and it can describe what the protocol delivered, but it cannot by itself establish that the protocol caused the differences in outcomes. Three threats are specific to this kind of comparison.
Selection. The central design question is how patients came to be in each group. If the protocol group differed systematically, for example by admission period, bed location or the clinicians caring for them, those differences could explain the outcomes. The abstract reports that baseline characteristics were similar between groups, which reduces but does not remove this concern, since similarity on measured characteristics says nothing about unmeasured ones.
Confounding. Patients who are well enough to get out of bed early are, for that reason alone, likely to leave the ICU sooner. A design without randomization must deal with this by adjustment. According to the abstract, the length of stay comparison was adjusted for three variables, namely weight relative to height, severity score on admission and whether vasopressors were needed, which addresses some but not all of the ways sicker patients differ.
Secular trend. If the protocol and usual care periods were not concurrent, other changes in the unit over time, in sedation practice, staffing or discharge processes, could affect length of stay. The design is stronger if the comparison was concurrent, and an appraiser needs the methods section to confirm which it was.
Execution: What Happened in This Study
The primary outcome was a process measure. The study's primary outcome was the proportion of surviving patients who received physical therapy, and the difference was large: 80% of protocol patients against 47% of usual care patients. Protocol patients were out of bed earlier, at a median of 5 rather than 11 days, and therapy was started in the ICU far more often, 91% against 13%. For a process outcome, the cohort design is adequate. The protocol was designed to change who received therapy and when, and it did; selection or confounding is unlikely to produce differences of this size in a process the protocol directly controlled.
Length of stay was secondary and restricted to survivors. The length of stay findings, 5.5 against 6.9 days in the ICU and 11.2 against 14.5 days in hospital, are reported for survivors. This matters. If more patients died in one group, the survivors in that group are a selected subset, and comparing survivors' length of stay can produce a difference even when the intervention has no effect. The abstract states that outcome data reflect survivors but does not report deaths by group, so the size of this bias cannot be judged from the summary.
Safety and cost were reported in a limited way. No untoward events occurred during mobility sessions, and there was no cost difference between arms including the mobility team. These are useful findings for feasibility. The safety finding refers to events during sessions, which is a narrow window, and the cost analysis included survivors and nonsurvivors, which is a strength.
Verdict
The study supports, with reasonable confidence, the claim that a nurse, nursing assistant and physical therapist team using a protocol can start therapy earlier and more often in ventilated medical ICU patients without adverse events during sessions and without raising costs. It supports the length of stay claim only weakly, and the reasons stack on one another: the outcome was secondary, adjusted for a limited set of confounders and measured in survivors only, in a design that cannot rule out selection. For the review, the study contributes most to the question of feasibility and least to the question of benefit. Its findings were later tested by the same research group in a randomized trial of standardized rehabilitation, in which hospital stays were the same length in both arms (Morris et al., 2016). That result is consistent with the appraisal's caution about the cohort's length of stay finding.
What the Appraisal Changes in the Review
The cohort study will be cited in the review for feasibility and process change, not for length of stay, and the sentences that use it will say so. Its place in the evidence table is unchanged, but the appraisal note will say that its outcomes reflect survivors. If the full methods confirm a concurrent comparison, the selection concern will be noted as reduced; if not, secular trend will be added as a limitation. Either way, the review will not use this study to support a claim that mobilization shortens length of stay.
References
Moola, S., Munn, Z., Tufanaru, C., Aromataris, E., Sears, K., Sfetcu, R., Currie, M., Lisy, K., Qureshi, R., Mattis, P., & Mu, P.-F. (2020). Systematic reviews of etiology and risk. In E. Aromataris & Z. Munn (Eds.), JBI manual for evidence synthesis. JBI.
Morris, P. E., Berry, M. J., Files, D. C., Thompson, J. C., Hauser, J., Flores, L., Dhar, S., Chmelo, E., Lovato, J., Case, L. D., Bakhru, R. N., Sarwal, A., Parry, S. M., Campbell, P., Mote, A., Winkelman, C., Hite, R. D., Nicklas, B., Chatterjee, A., & Young, M. P. (2016). Standardized rehabilitation and hospital length of stay among patients with acute respiratory failure: A randomized clinical trial. JAMA, 315(24), 2694-2702. https://doi.org/10.1001/jama.2016.7201
Morris, P. E., Goad, A., Thompson, C., Taylor, K., Harry, B., Passmore, L., Ross, A., Anderson, L., Baker, S., Sanchez, M., Penley, L., Howard, A., Dixon, L., Leach, S., Small, R., Hite, R. D., & Haponik, E. (2008). Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Critical Care Medicine, 36(8), 2238-2243. https://doi.org/10.1097/CCM.0b013e318180b90e
Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasi-experimental designs for generalized causal inference. Houghton Mifflin.
What the NURS 8710 Week 5 instructions ask for
Expect the appraisal paper to work through one study in depth, judging how far its conclusions can be trusted. Start by stating exactly what the study claims, in its own words, so the target is fixed. Then separate two questions: what the design can establish in principle, and how well this study was executed. Name the specific threats the design faces rather than repeating general cautions about causation. Examine how outcomes were chosen, measured and analyzed, and note anything the report leaves unclear. Use a recognized appraisal tool to structure your thinking. End with a verdict that says which claims the study supports and how strongly, and explain how the appraisal changes the way the study will be used in your review.
Inside the NURS 8710 Week 5 example
The first section quotes the study's conclusion and explains why design and execution are kept apart, citing the JBI checklist and Shadish and colleagues. The design section describes the 165 versus 165 comparison and discusses selection, confounding and secular trend under italic labels. The execution section treats the process outcome, the survivor-only length of stay figures and the safety and cost findings in turn, with the abstract's numbers. The verdict separates strong support for feasibility from weak support for length of stay and points to the later randomized trial. A final section says how the cohort will be cited in the review and what the full methods could change.
Where the marks sit in the NURS 8710 Week 5 rubric
Appraisals are generally judged on accurate description of the study, correct identification of design-specific threats, careful assessment of execution and a proportionate verdict. Faculty reward appraisals that separate what a design can support from what a particular study achieved. Credit rises when threats are named precisely, such as survivor bias, rather than described in general terms. A verdict that grades each claim separately shows more judgment than an overall rating. Linking the appraisal to later evidence or to the review's use of the study is often credited. Faithful reporting of the study's own figures matters throughout, since appraisal errors undermine everything built on them.
NURS 8710 Week 5 help: mistakes that cost marks
Appraisal papers often summarize the study and then list generic limitations, such as small sample or single site, without saying how they affect specific findings. Others reject a study for being nonrandomized without asking which of its claims depend on randomization. Some score a checklist without explaining the answers. Quote the study's conclusion, then test each part of it separately. Ask how patients came to be in each group, which outcomes were primary and who was included in each analysis. Our writers can prepare an appraisal of a study from your review, separating design from execution and ending with a clear verdict. Keep the verdict proportionate, since rejecting a study entirely is rarely justified.
Get a NURS 8710 Week 5 example written to your instructions
Pass along the study you were assigned, the appraisal tool named in your prompt and any length your section sets, and an example appraisal written to that tool comes back. First custom one is free, inside 24 to 48 hours. An ethics submission is written and signed by the candidate it belongs to, never assembled here.
More NURS 8710 papers and DNP samples
- NURS 8710 Week 1: Literature Review Purpose Post
- NURS 8710 Week 2: Search Strategy Record
- NURS 8710 Week 3: Inclusion Criteria Memo
- NURS 8710 Week 4: Evidence Table Example
- NURS 8710 Week 6: Appraisal Peer Critique
- NURS 8710 Week 7: Synthesis Matrix Example
- NURS 8710 Week 8: Thematic Synthesis Paper
- NURS 8710 Week 9: Gap Statement Example
- NURS 8710 Week 10: Literature Review Draft
- NURS 8710 Week 11: Review Finding Discussion Post
- NURS 8705 Week 5: Significance Argument
- NURS 8600 Week 5: DNP implementation midpoint report
- NURS 8546 Week 5: Delivery Mode Comparison
- NURS 8544 Week 5: Active Learning Design
NURS 8710 Week 5 questions, answered
Does every appraisal need a named tool?
Most sections require one and name it in the prompt, so that instruction governs. The example follows a tool's question set but writes answers as evidence rather than as ratings, since a completed checklist with no supporting text tells a reader what was concluded and nothing about why. Where no tool is specified, the design and execution split is a defensible substitute.
Is it acceptable to conclude a study is usable?
Entirely, and appraisals that reject everything are as unconvincing as ones that accept everything. The example keeps one of the study's conclusions and explains why that particular claim does not depend on the damaged comparison. Naming what survives is harder than naming what fails and is the part faculty most often find missing.
How much detail about the study belongs up front?
Enough that the appraisal can be read without the paper open, which usually means two or three sentences rather than a summary paragraph. The example quotes the conclusion and states the design, then introduces details as each becomes relevant to a specific point. Summarizing the whole study first tends to consume the words the analysis needs.
Where can I find a free NURS 8710 Week 5 sample paper?
The complete appraisal, design block, execution block and verdict, appears above and is free to read.
What does the NURS 8710 Week 5 appraisal conclude about length of stay?
That the cohort supports a shorter stay only weakly, because the outcome was secondary, adjusted for a few factors and reported for survivors in a design that cannot rule out selection.